Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Sven H. Loosen; Karel Kostev; Mark Luedde; Tom Luedde; Christoph Roderburg

doi:10.1007/s00432-021-03867-1

December 12, 2021Journal of Cancer Research and Clinical OncologyOpen Access

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

View Full Paper

Ask AI

Bookmark

Share

Key Points

To examine the relationship between serum-specific lipid profiles, particularly low levels of high-density lipoprotein (HDL) cholesterol, and the presence of cancer.
Assessed circulating serum lipid profiles with a specific focus on high-density lipoprotein cholesterol concentrations in relation to cancer occurrence.
Serum-specific lipid profiles demonstrate a significant positive association with cancer.
Low circulating high-density lipoprotein cholesterol levels strongly correlate with the presence of malignant disease.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observational analysis reveals positive associations between specific serum lipid profiles and cancer, suggesting altered lipid metabolism accompanies malignancy.

Abstract

Our data strongly support the hypothesis that serum-specific lipid profiles are positively associated with cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Loosen et al. (2021) studied this question.

synapsesocial.com/papers/69dbc0f9cebd566818835bd9 https://doi.org/10.1007/s00432-021-03867-1

View Full Paper

Ask AI

Bookmark

Share

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading